Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study.

Takami H, Washio K, Gotoh H.

Int J Nephrol. 2017;2017:6218129. doi: 10.1155/2017/6218129. Epub 2017 Aug 22.

2.

Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.

Umeda S, Kanda M, Sugimoto H, Tanaka H, Hayashi M, Yamada S, Fujii T, Takami H, Niwa Y, Iwata N, Tanaka C, Kobayashi D, Fujiwara M, Kodera Y.

BMC Cancer. 2017 Sep 1;17(1):610. doi: 10.1186/s12885-017-3629-2.

3.

Factors Associated With Psycho-Cognitive Functions in Patients With Persistent Pain After Surgery for Femoral Neck Fracture.

Kitayama A, Hida M, Takami H, Hirata N, Deguchi Y, Miyaguchi K, Nakazono M, Nakagawa R, Fukumoto N, Hamaoka K.

J Clin Med Res. 2017 Sep;9(9):771-775. doi: 10.14740/jocmr3104w. Epub 2017 Jul 27.

4.

Biochemical characterization of a new nicotinamidase from an unclassified bacterium thriving in a geothermal water stream microbial mat community.

Zapata-Pérez R, Martínez-Moñino AB, García-Saura AG, Cabanes J, Takami H, Sánchez-Ferrer Á.

PLoS One. 2017 Jul 27;12(7):e0181561. doi: 10.1371/journal.pone.0181561. eCollection 2017.

5.

Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer.

Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y.

World J Gastroenterol. 2017 Apr 14;23(14):2519-2526. doi: 10.3748/wjg.v23.i14.2519.

6.

GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.

Shimizu D, Kanda M, Tanaka H, Kobayashi D, Tanaka C, Hayashi M, Iwata N, Niwa Y, Takami H, Yamada S, Fujii T, Nakayama G, Fujiwara M, Kodera Y.

Sci Rep. 2017 Feb 6;7:42089. doi: 10.1038/srep42089.

7.

Prognostic relevance of SAMSN1 expression in gastric cancer.

Kanda M, Shimizu D, Sueoka S, Nomoto S, Oya H, Takami H, Ezaka K, Hashimoto R, Tanaka Y, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Oncol Lett. 2016 Dec;12(6):4708-4716. doi: 10.3892/ol.2016.5233. Epub 2016 Oct 6.

8.

The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy.

Shimizu D, Kanda M, Sugimoto H, Shibata M, Tanaka H, Takami H, Iwata N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y.

Int J Oncol. 2017 Feb;50(2):381-386. doi: 10.3892/ijo.2017.3833. Epub 2017 Jan 2.

9.

Complete genome sequence and expression profile of the commercial lytic enzyme producer Lysobacter enzymogenes M497-1.

Takami H, Toyoda A, Uchiyama I, Itoh T, Takaki Y, Arai W, Nishi S, Kawai M, Shin-Ya K, Ikeda H.

DNA Res. 2017 Apr 1;24(2):169-177. doi: 10.1093/dnares/dsw055.

10.

Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.

Komatsu T, Nomura T, Takami H, Sakamoto S, Mizuno K, Sekii H, Hatta K, Sugita M.

Intern Med. 2016;55(19):2893-2897. Epub 2016 Oct 1.

11.

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.

Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, Tanaka S, Mukasa A, Shirahata M, Shimizu S, Suzuki K, Saito K, Kobayashi K, Higuchi F, Uzuka T, Otani R, Tamura K, Sumita K, Ohno M, Miyakita Y, Kagawa N, Hashimoto N, Hatae R, Yoshimoto K, Shinojima N, Nakamura H, Kanemura Y, Okita Y, Kinoshita M, Ishibashi K, Shofuda T, Kodama Y, Mori K, Tomogane Y, Fukai J, Fujita K, Terakawa Y, Tsuyuguchi N, Moriuchi S, Nonaka M, Suzuki H, Shibuya M, Maehara T, Saito N, Nagane M, Kawahara N, Ueki K, Yoshimine T, Miyaoka E, Nishikawa R, Komori T, Narita Y, Ichimura K.

Acta Neuropathol Commun. 2016 Aug 8;4(1):79. doi: 10.1186/s40478-016-0351-2.

12.

An automated system for evaluation of the potential functionome: MAPLE version 2.1.0.

Takami H, Taniguchi T, Arai W, Takemoto K, Moriya Y, Goto S.

DNA Res. 2016 Jul 3. pii: dsw030. [Epub ahead of print]

13.

Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer.

Kanda M, Mizuno A, Tanaka C, Kobayashi D, Fujiwara M, Iwata N, Hayashi M, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Takami H, Niwa Y, Murotani K, Kodera Y.

Medicine (Baltimore). 2016 Jun;95(24):e3781. doi: 10.1097/MD.0000000000003781.

14.

Short-term outcomes after conventional transthoracic esophagectomy.

Niwa Y, Koike M, Hattori M, Iwata N, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M, Kodera Y.

Nagoya J Med Sci. 2016 Feb;78(1):69-78.

15.

NRAGE promotes the malignant phenotype of hepatocellular carcinoma.

Shimizu D, Kanda M, Sugimoto H, Sueoka S, Takami H, Ezaka K, Tanaka Y, Hashimoto R, Okamura Y, Iwata N, Tanaka C, Yamada S, Fujii T, Nakayama G, Koike M, Nomoto S, Fujiwara M, Kodera Y.

Oncol Lett. 2016 Mar;11(3):1847-1854. Epub 2016 Jan 15.

16.

Functional Classification of Uncultured "Candidatus Caldiarchaeum subterraneum" Using the Maple System.

Takami H, Arai W, Takemoto K, Uchiyama I, Taniguchi T.

PLoS One. 2015 Jul 21;10(7):e0132994. doi: 10.1371/journal.pone.0132994. eCollection 2015.

17.

Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy.

Hashimoto R, Kanda M, Takami H, Shimizu D, Oya H, Hibino S, Okamura Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y.

Oncol Lett. 2015 Mar;9(3):1201-1206. Epub 2014 Dec 23.

18.

Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.

Kanda M, Nomoto S, Oya H, Hashimoto R, Takami H, Shimizu D, Sonohara F, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Murotani K, Fujiwara M, Kodera Y.

J Exp Clin Cancer Res. 2014 Oct 22;33:88. doi: 10.1186/s13046-014-0088-3.

19.

Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.

Kanda M, Nomoto S, Oya H, Shimizu D, Takami H, Hibino S, Hashimoto R, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

J Exp Clin Cancer Res. 2014 Aug 6;33:66. doi: 10.1186/s13046-014-0066-9.

20.

Novel diagnostics for aggravating pancreatic fistulas at the acute phase after pancreatectomy.

Kanda M, Fujii T, Takami H, Suenaga M, Inokawa Y, Yamada S, Kobayashi D, Tanaka C, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y.

World J Gastroenterol. 2014 Jul 14;20(26):8535-44. doi: 10.3748/wjg.v20.i26.8535.

Supplemental Content

Loading ...
Support Center